• LinkedIn
SFL Regulatory Affairs & Scientific Communication Ltd.
  • About SFL
    • Why SFL
    • Team
    • Associations
    • History
    • Awards
    • Ethics
  • Services
    • Regulatory Affairs
    • Quality Assurance & GxP Compliance
    • Medical Affairs & Communication
    • Market Access & Reimbursement
    • Public Affairs & Regulatory Intelligence
    • Medical Devices, Combination Products and IVDs
    • Pharmacovigilance & Clinical Safety
    • Supply Chains of Medicines and Devices
    • Legal & Healthcare Compliance
    • Swiss Support
    • UK Support
    • Clinical Trials support
  • Clients
    • Testimonials
    • Cases
  • Trainings
    • Customized training
    • Webinars
  • News
    • News
    • Newsletter
  • Careers
  • Contact
  • Search
  • Menu Menu

SFL CEO to co-chair DIAmond regulatory session at DIA Europe 2020 meeting

SFL’s CEO Shayesteh Fürst-Ladani representing the Medtech & Pharma Platform (MPP) will co-chair a DIAmond session at DIA Europe 2020 (#DMD11; 29 June‑ 3 July) on emerging and transforming technologies entitled “Does the current regulatory framework enable future science and technology along the product lifecycle?”. The session will be co-chaired by Sabine Atzor from Roche representing EFPIA, and panel members are Zaide Frias (European Medicines Agency), Ceri Thompson (DG CNECT, European Commission), Tapani Piha (FIPRA), and David Haerry (EATG).

Shayesteh is an expert on innovative medical devices, pharmaceuticals and associated regulations. She holds positions as President of the MPP, is a member of the expert group of the BIOPÔLE Digital Health Hub (DH2), and is a special coach for the Swiss Innovation Agency, Innosuisse. She also recently published an article on regulatory approval of software and digital healthcare devices with members of the SFL Medical Devices team.

Shayesteh would be happy to meet with you at SFL’s virtual booth, or you can contact SFL to arrange a call to discuss how SFL’s expert service areas, covering Medical Devices, Combination Products, Regulatory Affairs, Medical Affairs, Quality Assurance and Supply Chain, can support you in developing and implementing regulatory strategies for placing your innovative health ideas and new technologies onto the market.

  • News
  • Newsletter

Switzerland – Main Office

SFL Regulatory Affairs & Scientific Communication GmbH
Aeschenvorstadt 52 | CH-4051 Basel
Email: office@sfl-services.com
Phone: +41 61 361 9443

© Copyright 2023 - SFL Regulatory Affairs & Scientific Communication GmbH | Terms and Conditions | Privacy Statement | Cookies Policy
Scroll to top